Investigator-Initiated Preclinical studies at CIC biomaGUNE aimed at combatting Glioblastoma Multiforme Research will ...
InnoCare Pharma Ltd, a Hong Kong-listed Chinese mainland biotech company, said on Thursday that its cancer drug ...
The report charts major advances in precision oncology and immunotherapy but also reveals stagnant survival for several ...
Sophie Kinsella, best known for her Shopaholic series, died at the age of 55 after a battle with glioblastoma, an aggressive ...
A Phase 3 trial found that combining eflornithine with lomustine significantly improved survival for patients with recurrent ...
In DUBLIN-3 non-squamous EGFR WT NSCLC patients who progressed after anti-PD-(L)1, Plinabulin + docetaxel showed consistent and clinically meaningful improvements in OS, PFS, and ORR, reinforcing ...
First patient in the world treated with Alpha DaRT® in the brain –- According to the National Brain Tumor Society, ...
A research team from the LKS Faculty of Medicine at the University of Hong Kong (HKUMed) has made a breakthrough in gastric ...
While targeted radiation can be an effective treatment for brain tumors, subsequent potential necrosis of the treated areas can be hard to distinguish from the tumors on a standard MRI.
Preoperative breast MRI did not improve LRR, DRFR, or OS outcomes in early-stage breast cancer patients. The trial involved ...
The new HER2DX central nervous system (CNS) progression score predicts risk of brain progression in advanced HER2+ breast cancer, addressing a major unmet need in identifying patients at the highest ...
Pfizer announces Tukysa added to first-line maintenance therapy extends median PFS by over 8 months in patients with HER2+ metastatic breast cancer: New York Friday, December 12, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback